Article Details

SK bioscience gets $140 M from CEPI to develop mRNA vaccines - BioSpectrum Asia

Retrieved on: 2022-10-26 06:12:49

Tags for this article:

Click the tags to see associated articles and topics

SK bioscience gets $140 M from CEPI to develop mRNA vaccines - BioSpectrum Asia. View article details on hiswai:

Excerpt

CEPI supports up to $40 million for early development of mRNA vaccine platform to SK bioscience; up to a further $100 million could be made ...

Article found on: www.biospectrumasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up